However, CXCL8 and other key neutrophil chemoattractants can be produced by cancer cells as well as a variety of stroma and immune cells, notably neutrophils and other myeloid cells themselves (64), and its predominant source may change over the course of transformation (62, 63). This evidence concerns the gene CXCL8 and cancer.